Alkermes (NASDAQ:ALKS – Free Report) had its price target lowered by Cantor Fitzgerald from $48.00 to $43.00 in a research ...

Uy Ear has given his Buy rating due to a combination of factors that highlight Alkermes’ strong performance and future potential. The company’s third-quarter 2024 results were robust ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

Dublin, Ireland-based Alkermes plc was formed by the Sep 2011 merger of Waltham, MA-based Alkermes, Inc. and Elan Drug Technologies ... global biopharmaceutical company that utilizes proprietary ...

The biopharma company's third-quarter report highlighted robust proprietary product performance, despite some weakness relating to its external revenue streams. Alkermes is a biopharmaceutical ...

Dublin, Ireland-based Alkermes plc was formed by the Sep 2011 merger of Waltham, MA-based Alkermes, Inc. and Elan Drug Technologies ... global biopharmaceutical company that utilizes proprietary ...

Alkermes plc (NASDAQ:ALKS – Get Free Report) saw a significant decline in short interest during the month of October. As of October 15th, there was short interest totalling 15,820,000 shares, a ...

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs ...

The company's EPS beat by $0.02 in the last quarter, leading to a 5.77% increase in the share price on the following day. Shares of Alkermes were trading at $28.1 as of October 22. Over the last ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In a report released yesterday, Joseph Thome from TD Cowen maintained a Buy rating on Prime Medicine, Inc. (PRME – Research Report). The ...

For growth investors, a company's financial strength ... plc was formed by the Sep 2011 merger of Waltham, MA-based Alkermes, Inc. and Elan Drug Technologies (EDT), the drug delivery unit of ...